MedTrace Logo

ADHD Medication and Predictors of Treatment Outcome

NCT02136147 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 632

Last updated 2023-10-17

No results posted yet for this study

Summary

ADHD medication of children and adolescents is becoming increasingly common. Clinical experience and scientific studies have proven that approximately 30% of children/adolescents with ADHD do not benefit from this treatment. However, there is insufficient knowledge about who these children are. All children and adolescents, who start treatment with ADHD medication at public Child and Adolescent Psychiatry units in Stockholm, on Gotland, an in Västerbotten, will be asked to participate in the study. The investigators intend to monitor the patients´clinical symptoms and possible side-effects after treatment start. The investigators will collect background information and saliva samples from the patient and his/her parents to be able to study if there are any genetic (hereditary) or other markers that can predict positive or negative outcomes of the ADHD medication. With this information, the investigators aim at, to a greater extent, be able to individualize treatment choices for children and adolescents with ADHD without unnecessary, costly and possibly unfavorable treatment attempts.

Conditions

  • Attention Deficit Disorder With Hyperactivity (ADHD)

Interventions

DRUG

methylphenidate medication

DRUG

atomoxetine medication

DRUG

lisdexamphetamine medication

DRUG

guanfacine medication

Sponsors & Collaborators

Eligibility

Min Age
6 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2021-07-31
Completion
2022-06-30

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02136147 on ClinicalTrials.gov